heptanoate (Bromoxynil heptanoate) (CAS No. 56634–95–8) (provided for in subheading 3808.93.15) Free No change No change On or before 12/31/2025 . 11487. Sulfometuron-methyl and Metsulfuron-methyl formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.24.18 Formulations of methyl 2-[(4,6-dimethylpyrimidin-2-yl)carbamoylsulfamoyl] benzoate (Sulfometuron-methyl) (CAS No. 74222–97–2) and methyl 2-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoylsulfamoyl] benzoate (Metsulfuron-methyl) (CAS No. 74223–64–6) and application adjuvants (provided for in subheading 3808.93.15) Free No change No change On or before 12/31/2025 . 11488. Chlorimuron-ethyl and Tribenuron-methyl formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.24.19 Formulations of ethyl 2-[(4-chloro-6-methoxypyrimidin-2-yl)carbamoylsulfamoyl] benzoate (Chlorimuron-ethyl) (CAS No. 90982–32–4) and methyl 2-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-methylcarbamoyl]sulfamoyl] benzoate (Tribenuron-methyl) (CAS No. 101200–48–0) and application adjuvants (provided for in subheading 3808.93.15) Free No change No change On or before 12/31/2025 . 11489. Formulations containing Tiafenacil Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.24.20 Formulations containing methyl 3-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenyl] sulfanylpropanoylamino]propanoate (Tiafenacil) (CAS No. 1220411–29–9) (provided for in subheading 3808.93.15) 0.9% No change No change On or before 12/31/2025 . 11490. Diuron 80 Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.24.21 Formulated products containing mixtures of 3-(3,4-dichlorophenyl)-1,1-dimethylurea (CAS No. 330–54–1) and application adjuvants (provided for in subheading 3808.93.15) Free No change No change On or before 12/31/2025 . 11491. Flazasulfuron